TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ, Xu R, Xu YY, Zhang X, Ni SL, Huang B, Chen AJ, Wei YZ, Wang S, Li WJ, Zhang Q, Li G, Li XG, Wang J.
Han MZ, et al. Among authors: xu yy, xu r.
J Exp Clin Cancer Res. 2017 Nov 6;36(1):155. doi: 10.1186/s13046-017-0619-9.
J Exp Clin Cancer Res. 2017.
PMID: 29110682
Free PMC article.